These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3919601)

  • 1. Bypass or amputation? Concomitant review of bypass arterial grafting and major amputations.
    Gregg RO
    Am J Surg; 1985 Mar; 149(3):397-402. PubMed ID: 3919601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial.
    Devine C; Hons B; McCollum C
    J Vasc Surg; 2001 Mar; 33(3):533-9. PubMed ID: 11241124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTFE bypass grafting to isolated popliteal segments in critical limb ischaemia.
    Loh A; Chester JF; Taylor RS
    Eur J Vasc Surg; 1993 Jan; 7(1):26-30. PubMed ID: 8454073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to editor re: Dacron or PTFE for above-knee femoropopliteal bypass. A multicenter randomised study.
    Bruijninckx CM
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):749; author reply 749. PubMed ID: 17919944
    [No Abstract]   [Full Text] [Related]  

  • 5. The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein.
    Cheshire NJ; Wolfe JH; Noone MA; Davies L; Drummond M
    J Vasc Surg; 1992 Jan; 15(1):167-74; discussion 174-5. PubMed ID: 1728675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts.
    Jackson MR; Belott TP; Dickason T; Kaiser WJ; Modrall JG; Valentine RJ; Clagett GP
    J Vasc Surg; 2000 Sep; 32(3):498-504; 504-5. PubMed ID: 10957656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-year result of 305 supragenual femoro-popliteal bypasses].
    Ptakovsky H; Hold M; Raynoschek H; Hagmüller G
    Vasa Suppl; 1992; 37():45-7. PubMed ID: 1481097
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing patency of femoropopliteal artery bypass grafts.
    Buda JA; Weber CJ; McAllister FF; Voorhees AB
    Am J Surg; 1976 Jul; 132(1):8-12. PubMed ID: 952340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic indicators in femoropopliteal and distal bypass grafts.
    Barry R; Satiani B; Mohan B; Smead WL; Vaccaro PS
    Surg Gynecol Obstet; 1985 Aug; 161(2):129-32. PubMed ID: 4023893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia.
    O'Riordain DS; Buckley DJ; O'Donnell JA
    Am J Surg; 1992 Aug; 164(2):129-31. PubMed ID: 1636892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concept of knee salvage: why does a failed femorocrural/pedal arterial bypass not affect the amputation level?
    Panayiotopoulos YP; Reidy JF; Taylor PR
    Eur J Vasc Endovasc Surg; 1997 May; 13(5):477-85. PubMed ID: 9166271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting.
    Timaran CH; Stevens SL; Grandas OH; Piercy KT; Freeman MB; Goldman MH
    J Vasc Surg; 2000 Sep; 32(3):506-16; 516-8. PubMed ID: 10957657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft type for femoro-popliteal bypass surgery.
    Ambler GK; Twine CP
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001487. PubMed ID: 29429146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidentally detected stenoses proximal to grafts originating below the common femoral artery: do they affect graft patency or warrant repair in asymptomatic patients?
    Treiman GS; Ashrafi A; Lawrence PF
    J Vasc Surg; 2000 Dec; 32(6):1180-9. PubMed ID: 11107091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
    Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
    J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patency of femoropopliteal and femorotibial grafts after outflow revascularization (jump grafts) to bypass distal disease.
    Andros G; Harris RW; Dulawa LB; Oblath RW; Salles-Cunha SX
    Surgery; 1984 Nov; 96(5):878-85. PubMed ID: 6495176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.
    Suckow BD; Kraiss LW; Stone DH; Schanzer A; Bertges DJ; Baril DT; Cronenwett JL; Goodney PP;
    Ann Vasc Surg; 2013 Nov; 27(8):1134-45. PubMed ID: 24011814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic critical leg ischemia: revascularization of the isolated popliteal segment in comparison with femoro-distal bypass].
    Mosimann UP; Stirnemann P
    Vasa; 1995; 24(1):49-55. PubMed ID: 7725779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
    Assadian A; Eckstein HH;
    J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.